Literature DB >> 20102901

Peripheral vascular endothelial function in patients with hypertrophic cardiomyopathy.

Kevin S Heffernan1, Craig A Napolitano, Martin S Maron, Eshan A Patvardhan, Ayan R Patel, Natesa G Pandian, Richard H Karas, Jeffrey T Kuvin.   

Abstract

Patients with hypertrophic cardiomyopathy (HC) have coronary microvascular dysfunction, which is an independent predictor of adverse left ventricular remodeling, systolic dysfunction, and mortality in these patients. Whether these defects in vasomotor function are localized to the coronary arteries or whether systemic vasomotor dysfunction is present in patients with HC has not yet been adequately examined. The aim of this study was to test the hypothesis that patients with HC have altered peripheral vascular endothelial function. Subjects without coronary artery disease (CAD) and those with CAD served as negative and positive controls, respectively. Conduit artery endothelium-dependent vasomotion was assessed with ultrasound by measuring flow-mediated dilation of the brachial artery. Flow-mediated dilation was lower in patients with HC compared with those without CAD (p <0.05) but was similar in patients with CAD (p = NS). In conclusion, vasomotor dysfunction in HC is not restricted to the coronary vasculature. Patients with HC have impaired peripheral conduit vessel endothelial function, and the magnitude of impairment is similar to that seen in older patients with advanced CAD.

Entities:  

Mesh:

Year:  2010        PMID: 20102901      PMCID: PMC2919165          DOI: 10.1016/j.amjcard.2009.08.658

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Limited maximal vasodilator capacity of forearm resistance vessels in patients with hypertrophic cardiomyopathy.

Authors:  T Imaizumi; A Takeshita; K Yamamoto; M Nakamura; K Sueishi
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

2.  Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy.

Authors:  P P Dimitrow; M Krzanowski; R Nizankowski; A Szczeklik; J S Dubiel
Journal:  Cardiovasc Drugs Ther       Date:  2000-12       Impact factor: 3.727

Review 3.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

4.  Evidence for a systemic defect of resistance-sized arterioles in hypertrophic cardiomyopathy.

Authors:  R Pedrinelli; M Spessot; G Chiriatti; R Gistri; P Salvadori; G Catapano; G Panarace; L Papi; A L'Abbate; P G Camici
Journal:  Coron Artery Dis       Date:  1993-01       Impact factor: 1.439

5.  Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease.

Authors:  J T Kuvin; A R Patel; K A Sliney; N G Pandian; W M Rand; J E Udelson; R H Karas
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

6.  Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women.

Authors:  D S Celermajer; K E Sorensen; D J Spiegelhalter; D Georgakopoulos; J Robinson; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1994-08       Impact factor: 24.094

7.  Close relation of endothelial function in the human coronary and peripheral circulations.

Authors:  T J Anderson; A Uehata; M D Gerhard; I T Meredith; S Knab; D Delagrange; E H Lieberman; P Ganz; M A Creager; A C Yeung
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

8.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

9.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

10.  Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

Authors:  R O Cannon; D R Rosing; B J Maron; M B Leon; R O Bonow; R M Watson; S E Epstein
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

View more
  4 in total

1.  Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy.

Authors:  Kevin S Heffernan; Martin S Maron; Eshan A Patvardhan; Richard H Karas; Jeffrey T Kuvin
Journal:  Am J Cardiol       Date:  2010-12-22       Impact factor: 2.778

2.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

3.  Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.

Authors:  E Fernlund; T Gyllenhammar; R Jablonowski; M Carlsson; A Larsson; J Ärnlöv; P Liuba
Journal:  Pediatr Cardiol       Date:  2017-03-30       Impact factor: 1.655

4.  Aortic biomechanics in hypertrophic cardiomyopathy.

Authors:  Hala Mahfouz Badran; Ghada Soltan; Nagla Faheem; Mohamed Fahmy Elnoamany; Mohamed Tawfik; Magdi Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2015-07-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.